Celyad is a clinical-stage biopharmaceutical company focused on the identification and development of specialized cell based therapies.

Research Grants 3 show all


$8.1M
2011

$9.1M
2013

$6.2M
2014

Patents 94show all

  • 39
    A61K - Preparations for medical, dental, or toilet purposes
  • 31
    C12N - Microorganisms or enzymes
  • 17
    A61B - Diagnosis
  • 17
    A61M - Devices for introducing media into, or onto, the body
  • 15
    A61J - Containers specially adapted for medical or pharmaceutical purposes
  • 10
    C07K - Peptides
  • 9
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 8
    G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
  • 6
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 4
    C12M - Apparatus for enzymology or microbiology

Clinical Trials 8show all

5Phase 33N/A

Contact Information

Mont-Saint-Guibert
Belgium